The option expires in 39 days, for a return of 5.8%. If I annualize this measure, the return is 54.7% [see below]. The fact pattern for this security is quite different when compared to my earlier ...

California's cannabis tax revenue exceeded $500 million in the first half of 2025. The state has collected over $7.3 billion in total cannabis tax revenue since January 2018. Cannabis products in ...

Cannabis seeds are readily available for purchase and transportation in all 50 states, so it's easier than it used to be to ...

Cannabis could be risky for women becoming or hoping to become pregnant. New research out today finds evidence that the drug can negatively affect women’s fertility. Scientists in Canada examined the ...

Scientists at Stellenbosch University have uncovered a rare class of plant compounds, flavoalkaloids, in Cannabis leaves for the first time. Using advanced two-dimensional chromatography and mass ...

Members of 13 families will receive keys to their new homes at a Hope Springs Greeley-Weld Habitat for Humanity event near ...

Some businesses are set up to succeed regardless of their leadership. Booming chipmaker Nvidia has become that type of business. It has strengths in both the hardware and software side of its industry ...

In early September, high schoolers from North Valley Career and Technology Center waded through hip-high prairie with plastic ...

Despite receiving more than 600 reports of "adverse events" for medicinal cannabis in the past three years, the Therapeutic Goods Administration (TGA) is yet to investigate the safety of most ...

Higher levels of tetrahydrocannabinol, or THC — a chemical in marijuana that produces a euphoric feeling or “high” — was linked with changes in how eggs mature and a possible increase in chromosome ...

Buyout firm GTCR agreed to acquire generic drugmaker Zentiva Group AS from Advent, adding to a flurry of health-care deals this year. The transaction is expected to be completed by early 2026, ...

Shares of biosimilar drugmaker Alvotech ALVO closed at $8.16 on Monday, near its 52-week low of $7.35. This underperformance is attributable to investor concerns over stiff competition in the ...